Cyclacel Pharmaceuticals Inc. Executes Warrant Exchange for 559,395 Shares of Common Stock
I'm PortAI, I can summarize articles.
Cyclacel Pharmaceuticals Inc. has executed a Warrant Exchange Agreement on September 4, 2025, with accredited investors, exchanging Series C common stock purchase warrants for 559,395 shares of common stock. The exchange was non-cash and the shares were issued without registration under the Securities Act of 1933, relying on Section 3(a)(9) exemption. The share price was not specified.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments